Skip to content
Our Company
Culture and Values
Leadership
Corporate Impact
Environmental, Social, and Governance
Product Donations
Charitable Giving
CME and Research Grants
Careers
Open Roles
Life at Emergent
Locations
Our Focus
Biological Threats
Opioid Crisis
Impact Map
Manufacturing Partnerships
Our Science
Pipeline
Publications
Our Products
Product and Medical Inquiries
Latest
Press Releases
Blog
Podcast
Media Statements
Media Resources
Investors
FOLLOW US
All Publications
Filter:
Program
Medical Countermeasures
Opioid Antagonist
Filter
September 25, 2019
GC-072: A Novel Therapeutic Candidate for Oral Treatment of Melioidosis and Infections Caused by Select Biothreat Pathogens
Read More
September 19, 2019
Comparative Immunogenicity and Efficacy of Thermostable (Lyophilized) and Liquid Formulation of Anthrax Vaccine Candidate AV7909
Read More
June 11, 2019
Repeat-Dose Toxicity Study of a Lyophilized Recombinant Protective Antigen-Based Anthrax Vaccine Adjuvanted With CpG 7909
Read More
August 5, 2017
Correlation Between Anthrax Lethal Toxin Neutralizing Antibody Levels and Survival in Guinea Pigs and Nonhuman Primates Vaccinated with the AV7909 Anthrax Vaccine Candidate
Read More
October 30, 2016
Licensure Strategy for Pre- and Post-Exposure Prophylaxis of Biothrax Vaccine: The First Vaccine Licensed Using the FDA Animal Rule
Read More
March 17, 2016
Randomized, Double-Blind, Active-Controlled Study Evaluating the Safety and Immunogenicity of Three Vaccination Schedules and Two Dose Levels of AV7909 Vaccine for Anthrax Post-Exposure Prophylaxis in Healthy Adults
Read More
February 18, 2014
Enhanced Early Innate and T Cell-Mediated Responses in Subjects Immunized with Anthrax Vaccine Adsorbed Plus CPG 7909 (AV7909)
Read More
August 28, 2013
Evaluation of Intravenous Anthrax Immune Globulin for Treatment of Inhalation Anthrax
Read More
August 28, 2013
Effect of Anthrax Immune Globulin on Response to BioThrax (Anthrax Vaccine Adsorbed) in New Zealand White Rabbits
Read More
May 25, 2013
Randomized, Double-Blind, Placebo-Controlled, Safety and Immunogenicity Study of 4 Formulations of Anthrax Vaccine Adsorbed Plus CPG 7909 (AV7909) in Healthy Adult Volunteers
Read More
May 10, 2013
Evaluation of Immunogenicity and Efficacy of Anthrax Vaccine Adsorbed for Postexposure Prophylaxis
Read More
January 30, 2013
Pathology and Pathophysiology of Inhalational Anthrax in a Guinea Pig Model
Read More
1
2
3
4
